Advantage Alpha Capital Partners LP Xencor Inc Transaction History
Advantage Alpha Capital Partners LP
- $387 Million
- Q4 2024
A detailed history of Advantage Alpha Capital Partners LP transactions in Xencor Inc stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 13,548 shares of XNCR stock, worth $191,704. This represents 0.08% of its overall portfolio holdings.
Number of Shares
13,548
Previous 24,861
45.51%
Holding current value
$191,704
Previous $499,000
37.68%
% of portfolio
0.08%
Previous 0.12%
Shares
4 transactions
Others Institutions Holding XNCR
# of Institutions
199Shares Held
73.7MCall Options Held
1.7KPut Options Held
4.2K-
Black Rock Inc. New York, NY11.1MShares$157 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.98MShares$127 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.02MShares$113 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$86.9 Million6.6% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.04MShares$57.1 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $845M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...